Novel technology to improve pharmaceutical productivity

Current Opinion in Drug Discovery and Development

Volumn 2, Issue 3, 1999, Pages 239-243

  Krebs, Rolf ^a  

^a BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

Collaboration; Knowledge management; Novel technologies; Virtual organizations

Indexed keywords

ARTICLE; DRUG INDUSTRY; DRUG RESEARCH; ENVIRONMENTAL FACTOR; INFORMATION SCIENCE; INFORMATION SYSTEM; MANAGEMENT; PRODUCTIVITY;

EID: 0032965863     PISSN: 13676733     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Halliday RG. Drasdo AL, Lumley CE, Walker SR: The allocation of resources for R&D in the world's leading pharmaceutical companies. R&D Management (1997) 27(1):63-77.
2. Industry must set goals for the millenium. Marketletter (1998) June 8.
3. Japan's drugmakers shifting development Marketletter (1998) May 18.
4. Pharma firms must change or disappear. Scrip (1998) 2388:11.
5. Tariach G-M: Drug firms must step up discovery process for success. Drug Topics (1997)3:15.
6. More drugs - less time. Pharm Techn Europe (1997) 9(11 ):9.
7. Myshko D: The best pipelines. Med Ad News (1997) March 1.
8. Banerjee PK, Rosofsky M: Drug dicovery: The quest for innovation and productivity. Scrip Magazine (1997) 62:35-38.
9. Hills W, Rosen D, Gugliotti J: Dominating the era of outcomes. Pharmaceutical Executive (1998) 18(4):74-84.
10. Krinsky R, Jenkins AC: When worlds collide: The uneasy fusion of strategy and innovation. Strategy & Leadership (1997)25(4):36-41.
11. Omla SWF, van Engelen JML: Preparing for the 21 century. Res Techn Management (1998) 41(1):31-35.
12. Dorabjee S, Lumley CE, Cartwright S: Culture, innovation and successful development of new medicines - an exploratory study of the pharmaceutical industry.
13. Leadership & Organisation Development Journal (1998) 19(4):199-210.
14. Fairiey P: Drug discovery: Chemistry reclaims star status. Chemical Weefe(1998) 160(15):27-30.
15. Progress in combinatorial chemistry replaces search for biopharmaceuticals. Qualitative aspects of combinatorial chemistry are broadly discussed.
16. Danheiser S: Laboratory automation and robotics to play a major role in the drug discovery process. Genetic Engineering News (1997) 17(21):1.
17. Marshall A: Getting the right drug into the right patient. Nature Biotechnology (1997) 15(11):1249-1256.
18. Chiesa V, Manzini R: Managing virtual R and D organisations: Lessons from the pharmaceutical industry. Int J Technol Management (1997) 13(5):471 -485.
19. Bibby A: Protodigm the virtual drug developer. Flexible Working Journal (1998) 3(2):17-18.
20. Stevens T: The gene machine. Industry Week (1997) 246(25):168-175.
21. Pisano G-P: The development factory: Unlocking the potential of process innovation. Harvard Business School Press (1997) 343.
22. Lant T-K, Eisner, A-B: Pharmaceutical R and D in an era of managed healthcare using integrative teams to produce enduring competitive advantage. Int J Techn Management (1998)15(3):299-321.
23. Ciborra CU, Patriotta G: Groupware and teamwork in R&D: Limits to learning and innovation. R&D Management (1998) 28(1):43-52.